Rationally engineered cationic ferritin nanoparticles overcome pre-existing immunity to adenoviral vectors
Yilong Yang, Di Wang, Yaohui Li, Xiaofan Zhao, Mengran Yi, Xiaoyan Huang, Xiaodong Zai, Zhe Zhang, Shipo Wu, Jun Zhang, Lihua Hou, Junjie Xu, Wei Chen · 2026
Read Rationally engineered cationic ferritin nanoparticles overcome pre-existing immunity to adenoviral vectors by Yilong Yang, Di Wang, Yaohui Li, Xiaofan Zhao, Mengran Yi, Xiaoyan Huang, Xiaodong Zai, Zhe Zhang, Shipo Wu, Jun Zhang, Lihua Hou, Junjie Xu, Wei Chen (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13560401.txt.
Description
Yilong Yang and colleagues engineer a ferritin particle with a positive charge that cloaks adenovirus vaccine vectors against pre-existing immunity. Their 2026 study tackles a known weakness: many people already carry antibodies to adenovirus type 5, which blunt vaccines built on it. Guided tweaks added positive surface charges while keeping the ferritin cage's self-assembly intact.
The charged cages clumped electrostatically with the virus into supramolecular complexes. These complexes carried their genetic cargo into cells and animals better, and shrugged off neutralizing antibodies more fully. In mice already immune to the vector, nasal vaccination with complexed vaccines against SARS-CoV-2 or Hendra virus produced markedly higher antibody and neutralizing titers. Because ferritin is a human protein, the carrier itself sparked no anti-carrier response. The authors frame the pairing of viral vectors with protein nanocages as a general delivery plan.
Catalog record
| CREATOR | Yilong Yang, Di Wang, Yaohui Li, Xiaofan Zhao, Mengran Yi, Xiaoyan Huang, Xiaodong Zai, Zhe Zhang, Shipo Wu, Jun Zhang, Lihua Hou, Junjie Xu, Wei Chen |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 47883 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |